Skip to content

Medical-device intelligence

JTT: Susceptibility Test Powders, Antimicrobial

FDA product code JTT: Susceptibility Test Powders, Antimicrobial. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JTT
FDA device name
Susceptibility Test Powders, Antimicrobial
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

14 clearance records and 1 recall records in the covered releases, across 10 source company names and 1 product codes. Dated history runs from May 12, 1982 to Mar 24, 2016.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JTT · Susceptibility Test Powders, Antimicrobial141

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

15 matching records
Device / recordCompany in FDA recordSourceSource date
Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detection of beta-lactamase activity in bacte…Z-1921-2016 · JTTRemel IncRecallJun 7, 2016FDA record creation date
SENSITITRE 18-24 HOUR SUSCEPTIBILITY PLATES WITH SPARFLOXACINK983310 · JTTAccumed Intl., Inc.510(k)Dec 17, 1998FDA decision date
PASCO MIC AND MIC/ID PANELSK935805 · JTTPasco Laboratories, Inc.510(k)Jun 13, 1994FDA decision date
BACTEC PYRAZINAMIDE SUSCEPTIBILITY TESTK895362 · JTTBd Becton Dickinson Vacutainer Systems Preanalytic510(k)Dec 1, 1989FDA decision date
MODIFIED IMIPENEM SUSCEPTIBILITY POWDERK880574 · JTTMerck, Sharp & Dohme510(k)May 4, 1988FDA decision date
CIPRO (TM) DIAGNOSTIC POWDERK872081 · JTTMiles Pharmaceuticals510(k)Jun 15, 1987FDA decision date
NORFLOXACIN SUSCEPTIBILITY POWDERK864442 · JTTMerck, Sharp & Dohme510(k)Dec 11, 1986FDA decision date
IMIPENEM SUSCEPTIBILITY POWDERK855071 · JTTMerck, Sharp & Dohme510(k)Mar 6, 1986FDA decision date
IMIPENEM 10 MCG SENSI-DISC,CAT. # 31644/31645K855106 · JTTBd Becton Dickinson Vacutainer Systems Preanalytic510(k)Mar 6, 1986FDA decision date
IMIPENEM 10 MCG SENSITIVITY DISCSK855207 · JTTDifco Laboratories, Inc.510(k)Mar 6, 1986FDA decision date
GEN DIAGNOSTICS' IMIPENEM 10 MCG SUSCEPTIBITY DISKK860031 · JTTOrganon Teknika Corp.510(k)Mar 6, 1986FDA decision date
AZLIN AZLOCILIN SODIUM-DIAG. REAGENTK830758 · JTTMiles Laboratories, Inc.510(k)May 25, 1983FDA decision date
MOXALACTAMK822866 · JTTLilly Research Laboratories510(k)Dec 28, 1982FDA decision date
ANTITUBERCULOUS DRUGS (SIRE)K822329 · JTTBd Becton Dickinson Vacutainer Systems Preanalytic510(k)Sep 2, 1982FDA decision date
MEZLIN DIAGNOSTIC REAGENTK820578 · JTTMiles Pharmaceuticals510(k)May 12, 1982FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗